Lead Product(s) : Oxycodone Hydrochloride
Therapeutic Area : Neurology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Protega’s ROXYBOND™ Gets FDA Approval As Abuse-Deterrent Pain Management Option
Details : Roxybond (oxycodone HCl) is an opioid agonist indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Brand Name : Roxybond
Molecule Type : Small molecule
Upfront Cash : Not Applicable
October 29, 2024
Lead Product(s) : Oxycodone Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?
Reset All
